Carbohydrate antigens Lewis a and Lewis b act as tumor markers cooperating with CA19.9 in the management of PDAC patients
The concurrent quantification of Lea and Leb together with CA19.9 improves the management of PDAC patients.
Authors
- Delfina Tosi (ORCID: https://orcid.org/0000-0002-6130-2665)
- Anna Caretti (ORCID: https://orcid.org/0000-0001-6140-6969)
- Rossella Indellicato (ORCID: https://orcid.org/0000-0003-2134-4665)
- Daniela Pistillo (ORCID: https://orcid.org/0000-0002-7665-3783)
- Michele Dei (ORCID: https://orcid.org/0000-0001-7359-8558)
- Marco Trinchera (ORCID: https://orcid.org/0000-0003-0194-6933)
- Gaetano Bulfamante (ORCID: https://orcid.org/0000-0002-4929-7162)
- Enrico Opocher (ORCID: https://orcid.org/0000-0001-5668-3136)
- Aı́da Zulueta (ORCID: https://orcid.org/0000-0001-8295-6847)
- Alessandro Zerbi (ORCID: https://orcid.org/0000-0002-9176-0448)
- Enrico De Nicola
- Gennaro Nappo (ORCID: https://orcid.org/0000-0002-6048-898X)
- G. Scifo
- Claudia Cigala
Institutions
- University of Insubria (IT)
- Humanitas University (IT)
- University of Milan (IT)
- Istituti Clinici Scientifici Maugeri (IT)
- Ospedale San Paolo (IT)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Clinica Chimica Acta
- Published
- 2024-10-04
- DOI
- https://doi.org/10.1016/j.cca.2024.119990
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Mizutani Foundation for Glycoscience
- Università degli Studi dell'Insubria